Gating of ion channels and its modulation by lipids and drugs
Ion channels are integral membrane proteins that act, via electrochemical signaling, in cellular communication in the nervous system. Acting as selective filters, they participate in a series of biological processes important for the homeostasis of the organism. In neurons, by amplifying small variations in membrane potential, voltage-sensitive ion channels promote the initiation and propagation of action potentials. The relevance of these channels for the functioning of the neurons make them specific targets for many chemical compounds with pharmacological importance. Even more interesting is the observation that a single amino acid change in their structure can generate a series of pathological phenotypes. Multiple complementary techniques are used in LaNEF to understand the gating mechanism of voltage-sensitive ion channels, their association with some pathological conditions like periodic paralysis, and their pharmacological properties and modulation by lipids such as endocannabinoid ligands, cholesterol, and phospholipids.
Functional expression of Hv1 channel in glioblastoma multiform cells.
Anticancer activity of bioactive molecules
Cancer is one of the greatest public health challenges that, considering its many types, has become a destructive diasease wordwide. In essence, cancer is the disordered and uncontrollable growth of cells, forming tumors that can spread to other regions of the body. The side effects of conventional therapies for cancer determines the need for the development of novel bioagents with antitumor properties. In LaNEF we use a combination of biophysical and biochemical approches, including the design of new molecules with the aid of bioinformatics, biochemical assays and fluorescence microscopy, for the development of new agents and/or formulations against cancer. Special attention has been given to small cationic peptides, cannabinoids and other phytotherapeutic agents and inorganic nanoparticles.
Effects of mastoparan peptides on the viability of human glioblastoma multiform cells.